oral anticoagulant
Showing 26 - 50 of >10,000
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs
Completed
- Venous Thromboembolism
- Anticoagulants and Bleeding Disorders
- Oral Anticoagulant
-
Oakland, California
- +1 more
Oct 31, 2022
DOAC in Chinese Patients With Atrial Fibrillation
Recruiting
- Atrial Fibrillation
- +6 more
- Blood Tests
-
Hong Kong, Hong KongChinese University of Hong Kong
Oct 11, 2022
Non-valvular Atrial Fibrillation Trial in Hangzhou (Dual antiplatelet, Novel oral anticoagulant)
Recruiting
- Non-valvular Atrial Fibrillation
- Dual antiplatelet
- Novel oral anticoagulant
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Feb 27, 2023
NOACs Use in AF or VTE (SUNSHINE Registry)
Recruiting
- Atrial Fibrillation
- +2 more
- Patients with Atrial Fibrillation (AF) or venous thromboembolism (VTE)
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jun 6, 2022
Anticoagulants and Bleeding Disorders Trial in France (Quantra analyzer)
Recruiting
- Anticoagulants and Bleeding Disorders
- Quantra analyzer
-
Clermont-Ferrand, France
- +4 more
Feb 11, 2022
Direct Oral Anticoagulants for Treatment of Cerebral Venous
Recruiting
- Cerebral Venous Thrombosis
- Oral anticoagulant
-
Amsterdam, Noord-Holland, NetherlandsJonathan Coutinho
Feb 11, 2022
Oral Anticoagulant in Chinese Patients With NVAF
Not yet recruiting
- Nonvalvular Atrial Fibrillation
- adherence
-
Hangzhou, Zhejiang, ChinaChang Cuie
Jun 20, 2021
Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,
Not yet recruiting
- Percutaneous Coronary Intervention (PCI)
- +3 more
- P2Y12 inhibitor
- +2 more
-
Hasselt, Belgium
- +13 more
Jul 25, 2023
Atrial Fibrillation, Stroke Trial in Los Angeles (Oral anticoagulant)
Recruiting
- Atrial Fibrillation
- Stroke
- Oral anticoagulant
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 7, 2022
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +
Not yet recruiting
- Coronary Artery Disease
- +2 more
- Aspirin + Clopidogrel + Rivaroxaban
- Aspirin + Clopidogrel
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences, Fuwai Hospital
Dec 5, 2022
Atrial Fibrillation Trial in São Paulo (Anticoagulant)
Recruiting
- Atrial Fibrillation
-
São Paulo, Sao Paulo, BrazilMartino Martinelli Filho
Aug 27, 2021
Cardiovascular Drugs Adverse Reaction
Recruiting
- Pharmacogenetics
- +2 more
- Oral Anticoagulant, Direct-Acting
-
Zagreb, CroatiaUHC Zagreb
Mar 23, 2022
Learn More About Benefits and Side-effects of Drugs Rivaroxaban
Completed
- Atrial Fibrillation
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Many Sites, United KingdomMany facilities
Oct 27, 2021
Non-valvular Atrial Fibrillation Trial in Montpellier (Xarelto, Experimental: Personalized information intervention)
Completed
- Non-valvular Atrial Fibrillation
- Xarelto
- Experimental: Personalized information intervention
-
Montpellier, FranceHeart and vascular diseases service
Jul 19, 2021
Keeping Oral o Parental AnticoaguLation in Acute Phase of
Recruiting
- Cardioembolic Stroke
- +3 more
- Observation
-
Paris, France
- +2 more
Aug 2, 2022
Benign Prostatic Hyperplasia, Anticoagulant Adverse Reaction Trial in Toulouse (Maintenance of OAC in surgery of BPH by PVP.,
Recruiting
- Benign Prostatic Hyperplasia
- Anticoagulant Adverse Reaction
- Maintenance of OAC in surgery of BPH by PVP.
- Discontinuation of OAC in surgery of BPH by PVP.
-
Toulouse, FranceClinique Pasteur
Oct 19, 2022
Acute Ischemic Stroke, Atrial Fibrillation, Stenosis, Carotid Trial (Anticoagulant Oral, Anticoagulation combined with
Not yet recruiting
- Acute Ischemic Stroke
- +3 more
- Anticoagulant Oral
- Anticoagulation combined with antiplatelet therapy
- (no location specified)
Sep 21, 2023
Ventricular Tachycardia, Premature Ventricular Contraction, Stroke Trial in India, United States (DOAC, Aspirin)
Completed
- Ventricular Tachycardia
- +2 more
-
Kansas City, Kansas
- +4 more
Aug 30, 2021
Venous Thromboembolism Trial in France (Reduced dose of DOAC, Full dose of DOAC)
Recruiting
- Venous Thromboembolism
- Reduced dose of DOAC
- Full dose of DOAC
-
Amiens, France
- +38 more
Apr 21, 2022
Adherence, Medication, Statin Adverse Reaction, Anticoagulant Adverse Reaction Trial (Questionnaires to report barriers to
Recruiting
- Adherence, Medication
- +2 more
- Questionnaires to report barriers to medication adherence
-
Leeds, West Yorkshire, United KingdomLeeds Teaching Hospitals Trust
Aug 24, 2022
Mild Head Injury, Antiplatelets, and Anticoagulants
Completed
- Craniocerebral Trauma
- Cerebral Hemorrhage
- direct anticoagulant
- +2 more
-
Roma, Rm, ItalyFondazione Policlinico Universitario Agostino Gemelli - IRCCS
Mar 29, 2022
Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin
Completed
- Venous Thromboembolism
- +3 more
- Rivaroxaban 20 MG [Xarelto]
- +2 more
-
Metepec, Estado De Mexico, MexicoInstituto Mexicano Del Seguro Social
Aug 24, 2022
Prothrombin Complex Factor Deficiency Trial in Austria, Hungary (Prothrombin complex concentrate (coagulation factors IX, II,
Completed
- Prothrombin Complex Factor Deficiency
- Prothrombin complex concentrate (coagulation factors IX, II, VII and X in combination)
-
Feldkirch, Austria
- +5 more
Apr 30, 2021
Anticoagulants in Patients With Venous Thromboembolism in Korea
Completed
- Venous Thromboembolism
- Parenteral anticoagulant
- +5 more
-
Seongnam-si, Korea, Republic of
- +1 more
May 20, 2022